Silo Pharma, Inc.
SILO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 0% | 1.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 91.9% | 91.9% | 91.9% | 93% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -6,077% | -5,029.3% | -5,416.2% | 5,872.6% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -6,092.6% | -5,132.6% | -5,420.9% | 5,477.9% |
| EPS Diluted | -1.19 | -1.2 | -1.71 | 1.3 |
| % Growth | 0.8% | 29.8% | -231.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |